Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Am Geriatr Soc. 2019 May;67(5):928–936. doi: 10.1111/jgs.15934

Figure 1: Pre- and post- treatment data for (a) frailty, (b) Functional Assessment of Cancer Therapy-Cognition (FACT-Cog) total score, (c) the Controlled Oral Word Association (COWA) test, (d) the Trail Making Test (TMT) A scores, and (e) Delayed Match to Sample (DMS) at the 12-second delay and (f) Rapid Visual Processing (RVP) in breast cancer patients (dark gray) age ≥50 years versus age-matched non-cancer controls (light gray).

Figure 1:

The data points show the unadjusted mean and the 95% confidence interval. A1: pre-chemotherapy, A2: post-chemotherapy, A3: six months post-chemotherapy. Lower scores indicate lower performance on FACT-Cog, COWA, DMS, and RVP. Higher scores indicate lower performance on the Frailty Score and TMT.